HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.

Abstract
A double-blind trial was carried out to compare the combination of 25 mg bemetizide plus 50 mg triamterene ('Hypertane') and 0.25 mg cyclopenthiazide plus 600 mg potassium chloride ('Navidrex' K) in the treatment of mild to moderate essential hypertension. Two well matched groups of patients were treated for periods of 6 weeks with one or other of the drugs under test. There were 2-week placebo run-in and run-out periods. Blood pressure and laboratory investigations were performed every 2 weeks during the trial period. Both treatments resulted in similar overall statistically significant reductions in blood pressure during the trial. With bemetizide/triamterene, mean lying blood pressure decreased by 11.1/11.2 mmHg and mean standing blood pressure by 15.9/10.3 mmHg; with cyclopenthiazide/potassium chloride the corresponding reductions were 14.9/12.1 mmHg and 9.1/11.7 mmHg. The fact that some of the observed overall reduction seen with both drugs was due to 'placebo effect' is discussed but the clinical importance of overall changes is stressed. There were no significant differences between changes in blood pressure with the two treatments. Biochemical changes were those expected with thiazide diuretics. However, the decrease in potassium and increases in urea and uric acid levels were less with bemetizide/triamterene than with cyclopenthiazide/potassium chloride. Clinical tolerance of both treatments was good.
AuthorsR Wray, K G Benton, D Whitehill, B Wright, W Weener, J R Whittington
JournalCurrent medical research and opinion (Curr Med Res Opin) Vol. 8 Issue 9 Pg. 665-74 ( 1983) ISSN: 0300-7995 [Print] England
PMID6365467 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Benzothiadiazines
  • Diuretics
  • Drug Combinations
  • Sodium Chloride Symporter Inhibitors
  • Potassium Chloride
  • dehydrosanol
  • Cyclopenthiazide
  • Triamterene
Topics
  • Adolescent
  • Adult
  • Aged
  • Benzothiadiazines (administration & dosage)
  • Blood Pressure (drug effects)
  • Body Weight (drug effects)
  • Clinical Trials as Topic
  • Cyclopenthiazide (administration & dosage)
  • Diuretics
  • Double-Blind Method
  • Drug Combinations
  • Female
  • Humans
  • Hypertension (drug therapy, physiopathology)
  • Male
  • Middle Aged
  • Potassium Chloride (administration & dosage)
  • Sodium Chloride Symporter Inhibitors (administration & dosage)
  • Triamterene (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: